# Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis

> **NCT04345458** · PHASE3 · COMPLETED · sponsor: **Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.** · enrollment: 640 (actual)

## Conditions studied

- Ankylosing Spondylitis

## Interventions

- **DRUG:** prefilled liquid etanercept(Yisaipu)
- **DRUG:** lyophilized etanercept powder(Yisaipu)

## Key facts

- **NCT ID:** NCT04345458
- **Lead sponsor:** Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-06
- **Primary completion:** 2015-07-13
- **Final completion:** 2015-07-20
- **Target enrollment:** 640 (ACTUAL)
- **Last updated:** 2020-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04345458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04345458, "Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04345458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*